Search bioRxiv⌕ Search

Biology subjects

Verlaan, T.

Publications and source records attributed to Verlaan, T..

2 recordsLinked to original sources

GONNECT: A Gene Ontology-guided Neural Network for Explainable Cancer Typing

Biologically-informed neural networks (BINNs) embed prior knowledge such as the Gene Ontology (GO) into their architecture to produce structurally interpretable representations, yet whether and how this prior improves performance or interpretation remains unclear. Here, we introduce GONNECT, a BINN incorporating GO into an autoencoder. We evaluate GO constraints in the encoder, decoder, or both on RNA-seq tumour samples from The Cancer Genome Atlas (TCGA), comparing against published BINNs (OntoVAE and VEGA), randomized-prior controls, and an unconstrained baseline. Across metrics, GO structure adds little to reconstruction or latent-space organization, frequently matched by randomized or unconstrained models. Its value lies in node activations, particularly in the encoder, where they correlate with a gene set enrichment analysis (GSEA)-derived reference. GONNECT-SL introduces regularized connections outside GO, but these soft links are unstable across seeds and concentrate where the ontology is sparse, appearing to compensate for the priors constraints rather than reveal new biology. They recover near-unconstrained reconstruction, keeping encoder activations interpretable. We identify the soft-link encoder as most promising. Our results clarify what biological priors contribute: their value lies not in the identity of the imposed connections or in improved performance, but in organizing activations into biologically meaningful units that can be interrogated directly.

bioinformatics↗

scAGG: Sample-level embedding and classification of Alzheimer's disease from single-nucleus data

Identifying key cell types and genes in Alzheimers Disease (AD) is crucial for understanding its pathogenesis and discovering therapeutic targets. Single-cell RNA sequencing technology (scRNAseq) has provided unprecedented opportunities to study the molecular mechanisms that underlie AD at the cellular level. In this study, we address the problem of sample-level classification of AD using scRNAseq data, where we predict the disease status of entire samples from the gene expression profiles of their cells, which are not necessarily all affected by the disease. We introduce scAGG (single-cell AGGregation), a sample-level classification model that uses a sample-level pooling mechanism to aggregate single-cell embeddings, and show that it can accurately classify AD individuals and healthy controls. We then investigate the latent space learnt by the model and find that the model learns an ordering of the cells corresponding to disease severity. Genes associated with this ordering are enriched in AD-linked pathways, including cytokine signalling, apoptosis, and metal ion response. We also evaluate two attention-based models that perform on par with scAGG, but entropy analysis of their attention scores reveals limited interpretability value. As scRNAseq is increasingly applied to large cohorts and cell-level disease association annotations do not exist, our approach provides a way to classify phenotypes from single-cell measurements. The yielded cell- and sample-level severity scores may enable identification of AD-associated cell subtypes, paving the way for targeted drug development and personalized treatment strategies in AD. Code is available at: http://github.com/timoverlaan/scAGG

bioinformatics↗